No Detail Found!

Differentiation Syndrome; Post-ATRA/ATO Induction Therapy in Acute Promyelocytic Leukemia

Author(s)
Kanwal Karim Shalamar Nursing College, Lahore, Pakistan
Simab Pervaiz Shalamar Nursing College, Lahore, Pakistan
Ina Abdul Majeed The Aga Khan School of Nursing and Midwifery, Karachi, Pakistan
Sana Mushtaq Saida Waheed FMH College of Nursing, Lahore, Pakistan
Hina Arshad Saida Waheed FMH College of Nursing,Lahore,Pakistan
Abstract
Acute promyelocytic leukemia (APL) is a disease described as de??nite morphological andcytogenetical abnormalities and leads to coagulopathy leaving the patient in a life-threateningcondition. A speci??c chromosomal translocation of 15 and 17 chromosomes leads to retinoicacid receptor-a (RARa) and promyelocytic leukemia (PML) genes fusion that produces anabnormal gene mutation forming an oncogenic protein which is (PML-RARa). Those APLpatients, who have been treated with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO)usually ends up in a complicated condition called differentiation syndrome which is rarelysevere. This case report explains the 37-years old male diagnosed with acute promyelocyticleukemia and later developed a differentiation syndrome after initiation of all-trans retinoic acidand arsenic trioxide induction therapy
Publication Details
Page(s) 238-240
Published Journal: Pakistan Journal of Health Sciences, Volume: 4, Issue: 10, Year: 2023

Request the full text from PASTIC

Keywords
Acute, Leukemia, Differentiation Syndrome, Promyelocytic
0

Citations

0

Downloads

45

Views